IBEX Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

IBEX Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-361	Closed	-$225K	–	298
2021 Q3	$225K	Hold	361	–	–	0.04%	166
2021 Q2	$228K	Buy	+361	New	+$199K	0.05%	166
2019 Q3	–	Sell	-63	Closed	-$17K	–	208
2019 Q2	$17K	Buy	+63	New	+$15.5K	﹤0.01%	294
2017 Q4	–	Sell	-21,032	Closed	-$3.33M	–	103
2017 Q3	$3.33M	Sell	21,032 -618	-3%	-$97.7K	1.23%	32
2017 Q2	$3.5M	Buy	21,650 +1,968	+10%	+$320K	1.38%	25
2017 Q1	$3.04M	Buy	19,682 +858	+5%	+$118K	1.88%	22
2016 Q4	$2.24M	Buy	+18,824	New	+$2.15M	1.07%	33

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IBEX Wealth Advisors's IDXX Position: Q4 2021 in Review

IBEX Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 361 shares — an estimated $225K sold.

IBEX Wealth Advisors first reported a position in IDXX in Q4 2016 and held it in 7 quarters. The position peaked at $3.5M in Q2 2017. 1,106 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

IBEX Wealth Advisors reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
IBEX Wealth Advisors sold 361 Idexx Laboratories shares in Q4 2021, an estimated $225K.
IBEX Wealth Advisors first reported a position in Idexx Laboratories in Q4 2016 and held it in 7 quarters.
IBEX Wealth Advisors's Idexx Laboratories position peaked at $3.5M in Q2 2017.
1,106 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on IBEX Wealth Advisors's 13F filing for Q4 2021, filed 22 Feb 2022.